• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

byPaary BalakumarandAlex Chan
April 13, 2025
in Cardiology, Chronic Disease, Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The highest-ranking phenotypic predictors of head and neck cancer included past tobacco smoking, job code at baseline, pain experienced during the last month, qualifications, FVC (Z score), and blood pressure.

2. Single nucleotide polymorphisms were less important in predicting the risk of head and neck cancer than phenotypic variables. 

Evidence Rating Level: 2 (Good) 

Head and neck cancer (HNC) refers to malignant tumors in the nasal cavity, oral cavity, pharynx, and larynx and accounts for over 300,000 deaths worldwide. 50-75% of these cases are diagnosed at the “advanced” stage, creating the need for risk prediction models. This retrospective biobank study looked at 502,367 participants from the UK Biobank between 2006 and 2021 to identify the relative importance of known risk factors and to identify novel risk factors. Data on potential risk factor exposure was collected through questionnaires/interviews, phenotype screening, and genetic testing. At baseline, men were more likely to get HNC (p < 0.001). Additionally, HNC was associated with poor or fair overall health rating, lower BMI with lower body fat percentage, engaged in less physical activity, had long standing illness/disability, more medications taken, high blood pressure, greater hand grip strength, pain during the past month, lower household income, lower educational attainment, and used tobacco. Incident cases were more likely to drink alcohol, smoke, have wheezing in the chest, experience shortness of breath with walking, and consume processed meat 2-4 times/week. There is also a significant difference in single-nucleotide polymorphisms (SNPs) between HNC incident cases and controls (p < 0.001), including rs259919-G (ZNRD1ASP gene) SNPs being more common in HNC incidences whereas rs1131769-T (STING1 gene) and rs28419191-T (ECSCR – SMIM33 gene) SNPs were more prevalent in controls. The highest-ranking phenotypic predictors of head and neck cancer included past tobacco smoking, job code at baseline, pain experienced during the last month, qualifications, FVC (Z score), and blood pressure. Single nucleotide polymorphisms were less important in predicting risk of head and neck cancer than phenotypic variables as none of the studied 25 genes were in the top 50 predictors of HNC. 

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

Pfizer’s Talzenna combo significantly delays prostate cancer progression

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Dipeptidyl peptidase-4 inhibitors may be associated with an increased incidence of malignancy

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: cancerchronic diseasehead and heck canceroncologysmoking
Previous Post

Measuring metabolic energy expenditure for individuals with lower limb amputation

Next Post

2 Minute Medicine Rewind April 14, 2025

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival
Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Intrapartum serum prolactin may predict risk of postpartum diabetes
Chronic Disease

Dipeptidyl peptidase-4 inhibitors may be associated with an increased incidence of malignancy

March 26, 2026
High frequency of germline mutations observed in triple negative breast cancers
The Scan by 2 Minute Medicine®

Susie Wiles’ breast cancer diagnosis drives national screening surge

March 25, 2026
Next Post

2 Minute Medicine Rewind April 14, 2025

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Increased tirzepatide use for glycemic and weight control since United States market entry

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Repetitive transcranial magnetic stimulation may reduce the incidence of chronic postsurgical pain after thoracoscopic surgery
  • Renal point-of-care ultrasound may be effective at identifying patients with nephrolithiasis
  • Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.